Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rhythm Pharmaceuticals Inc.

62.63
-2.2100-3.41%
Volume:150.79K
Turnover:9.54M
Market Cap:3.98B
PE:-22.21
High:64.96
Open:64.84
Low:62.39
Close:64.84
Loading ...

Pamela J. Cramer, Chief Human Resources Officer, Reports Disposal of Common Shares of Rhythm Pharmaceuticals Inc

Reuters
·
Yesterday

David P. Meeker, President and CEO, Reports Disposal of Common Shares in Rhythm Pharmaceuticals Inc

Reuters
·
06 Jun

Rhythm Pharmaceuticals Inc. Publishes Presentation Highlighting Strong Setmelanotide Trial Results and Growth Strategy

Reuters
·
04 Jun

Hunter C. Smith, CFO of Rhythm Pharmaceuticals Inc., Reports Disposal of Common Shares

Reuters
·
04 Jun

Rhythm Pharmaceuticals Is Maintained at Buy by Stifel

Dow Jones
·
30 May

Rhythm Pharmaceuticals Inc : Stifel Raises Target Price to $94 From $78

THOMSON REUTERS
·
29 May

H.C. Wainwright Sticks to Their Buy Rating for Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
23 May

Rhythm Pharmaceuticals Set to Submit Supplemental New Drug Application for Setmelanotide in Treating Acquired Hypothalamic Obesity, Following Promising Phase 3 Results

Reuters
·
14 May

Rhythm Pharmaceuticals Announces New Data Presentations on Patients With Acquired or Congenital Hypothalamic Obesity (N=35) Treated With Setmelanotide for up to Nine Months in French Early-Access Program

THOMSON REUTERS
·
14 May

Rhythm Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $73 From $68

THOMSON REUTERS
·
08 May

Rhythm Pharmaceuticals Inc : Morgan Stanley Raises Target Price to $80.00 From $77.00

THOMSON REUTERS
·
08 May

Rhythm Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
08 May

Rhythm Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Rhythm Pharmaceuticals' Q1 Net Loss Narrows, Revenue Increases

MT Newswires Live
·
07 May

Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q1 Loss $0.81, vs. FactSet Est of $0.73 Loss

MT Newswires Live
·
07 May

Rhythm Pharmaceuticals Q1 EPS $(0.81) Misses $(0.70) Estimate, Sales $32.70M Miss $40.31M Estimate

Benzinga
·
07 May

BRIEF-Rhythm Pharmaceuticals Q1 Net Income USD -49.498 Million

Reuters
·
07 May

Rhythm Pharmaceuticals Inc - Cash on-Hand Expected to Support Operations Into 2027

THOMSON REUTERS
·
07 May

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

THOMSON REUTERS
·
07 May

EVP Yann Mazabraud Reports Disposal of Rhythm Pharmaceuticals Inc. Common Shares

Reuters
·
02 May